Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...
Vertex Pharmaceuticals (VRTX) reports Q4 earnings today. Investors are eager for updates on new drug launches and growth ...
Vertex Pharmaceuticals Inc. hit a major milestone on Thursday when the U.S. Food and Drug Administration approved its ...
But the real excitement lies in Vertex's push beyond CF, where years of investment are finally bearing fruit. All eyes are on Jan. 30, when the FDA weighs in on suzetrigine -- a potential game ...
Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX ... Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results